Detalhe da pesquisa
1.
Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT.
Blood
; 143(4): 370-374, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976451
2.
Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine.
J Thromb Haemost
; 22(4): 1046-1055, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159648
3.
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2.
NPJ Vaccines
; 8(1): 40, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927774
4.
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
J Exp Med
; 218(7)2021 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909009
5.
Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model.
PLoS One
; 15(12): e0244215, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33362201
6.
Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide.
Mol Ther Nucleic Acids
; 17: 601-614, 2019 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394429
7.
The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain.
PLoS One
; 12(2): e0171127, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28182673